Does Exercise Snacking Improve Muscle Function in Older Adults?

May 21, 2018 updated by: Mr Oliver Perkin, University of Bath
Muscle size declines at around 0.5-1% per year after 50 years of age, with muscle strength declining up to twice as fast as muscle size. This may eventually lead to loss of independence if tasks of daily living become too strenuous to be performed safely. Exercise is recognized as a safe and effective means to counteract muscle loss during aging, however access to gym equipment may be logistically challenging or unpalatable to older adults. This research is designed to investigate the effect of 28 days of home-based leg exercise that doesn't require exercise equipment or supervision (exercise snacking), accompanied with a daily protein supplement in the form of commercially available yogurt, on the skeletal muscle health (i.e. function and size) of independent, community-dwelling older adults. To achieve this, two groups will be compared; one group will undertake exercise snacking and consume a 150 g yogurt with the breakfast meal for four weeks, with the second group only receiving the daily yogurt with no exercise snacking.

Study Overview

Status

Completed

Conditions

Detailed Description

The study will require potential participants to undergo an eligibility screening with a member of the research team, followed by a period of seven days of habitual activity monitoring and 3 days of diet recording. Eligible participants will be allocated into study groups by way of minimization based on sex, age, BMI, and number of sit-to-stands performed in a minute. Participants will undertake two familiarisation sessions with strength, power, neural drive, and balance tests at least seven days apart, the first following eligibility screening and the second familiarisation session at least five days before the first main trial.

Thereafter, both groups will undertake a main trial the day before commencing 28 days of daily 150 g yoghurt supplement with the breakfast meal, with the exercise snacking group (ES) also undertaking two bouts of exercise snacking a day. The main trial will include measures of leg muscle function and neural drive, standing and single leg balance, and movement co-ordination during tasks of everyday ambulation. Participants will wear a physical activity monitor and pedometer for the seven days and record diet for three days during the last week of the intervention. The day after the intervention period, a follow-up main trial will be conducted as per the first main trial, followed by an optional qualitative interview regarding participant's experience of the trial.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Avon
      • Bath, Avon, United Kingdom, BA2 7AY
        • University of Bath

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 80 years (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Not underweight or obese (body mass index ≥20 and ≤ 30 kg/m2)
  • Not regularly engaging in recreational sports or structured exercise (once a week or more).
  • Non-smoker (for >5 years)
  • Healthy (see exclusion criteria)

Exclusion Criteria:

  • Any chronic illness, cardiac, pulmonary, liver, or kidney abnormalities, uncontrolled hypertension, peripheral arterial disease, insulin- or non-insulin dependent diabetes or other metabolic disorders - all ascertained through preliminary screening.
  • Individuals with a history of bone, joint or neuromuscular problems or a current musculoskeletal injury ascertained through preliminary screening.
  • Individuals with any joint replacement surgical implants or other artifacts containing metal.
  • Individuals with a clinically diagnosed allergy or intolerance of dairy products.
  • Individuals with contraindications to exercise including chest pain, dizziness, or loss of consciousness, or who have been instructed by their doctor to only do physical activity recommended by them.
  • Individuals who score less than 8 on the Short Physical Performance Battery or score zero on any component of the test.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise Snacking Group
For 28 days, this group will be asked to perform two 'exercise snacks' a day; once in the morning and once in the evening. They will also be asked to consume 150 g of yogurt with the breakfast meal. The yogurt will be provided by the researchers.

Each bout of exercise snacking consists of 5 exercise. Each exercise is performed for one minute, with aim of completing as many repetitions as possible of that exercise in that minute. One minute of rest is observed between each exercise of the exercise snack. The five exercises are; sit-to-stand from a chair, marching on the spot, seated knee extensions alternating legs, standing knee bends alternating legs, and standing calf raises. The sit-to-stand exercise is always performed first, with the number of repetitions achieved recorded, and subsequent exercises performed in any order without recording of repetitions.

Two exercise snacks are completed each day for 28 days; once in the morning and once in the evening, or at least separated by 2 hours.

Participants are asked to consume 150 g of yogurt (Arla, Skyr- natural flavour) with their breakfast meal. Participants may substitute the yogurt for another part of their regular breakfast, or add the yogurt to their regular breakfast, with participants asked to record a log book of daily yogurt consumption and to complete a three day food diary during the last week of the 28 day intervention period.
Other: Yogurt Only Group
For 28 days, this group will be asked to consume 150 g of yogurt with the breakfast meal. The yogurt will be provided by the researchers. Apart from consuming the yogurt, this group will be asked to continue their normal lifestyle.
Participants are asked to consume 150 g of yogurt (Arla, Skyr- natural flavour) with their breakfast meal. Participants may substitute the yogurt for another part of their regular breakfast, or add the yogurt to their regular breakfast, with participants asked to record a log book of daily yogurt consumption and to complete a three day food diary during the last week of the 28 day intervention period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
60 second sit to stand test
Time Frame: 28 days- change from pre- to post- intervention period
The participant is asked to stand up from sitting in a chair whilst keeping their arms folded across their chest, then return to the seated position as many times as possible in a minute.
28 days- change from pre- to post- intervention period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lower limb muscle power
Time Frame: 28 days- change from pre- to post- intervention period
Measured during leg pressing
28 days- change from pre- to post- intervention period
Lower limb movement outcome variability
Time Frame: 28 days- change from pre- to post- intervention period
Measured during leg pressing
28 days- change from pre- to post- intervention period
Lower limb muscle cross-sectional area
Time Frame: 28 days- change from pre- to post- intervention period
Measured using peripheral quantitative computed tomography at 66% distal calf length and 25% and 50% distal thigh length
28 days- change from pre- to post- intervention period
Lower limb muscle cross-sectional tissue density
Time Frame: 28 days- change from pre- to post- intervention period
Measured using peripheral quantitative computed tomography at 66% distal calf length and 25% and 50% distal thigh length
28 days- change from pre- to post- intervention period
Body composition
Time Frame: 28 days- change from pre- to post- intervention period
Measured using Dual Energy X-ray Absorptiometry
28 days- change from pre- to post- intervention period
Gastrocnemius and quadriceps muscle fibre pennation angle
Time Frame: 28 days- change from pre- to post- intervention period
Measured using ultrasonography at 66% distal length of calf length and 50% distal thigh length
28 days- change from pre- to post- intervention period
Gastrocnemius and quadriceps muscle fibre length
Time Frame: 28 days- change from pre- to post- intervention period
Measured using ultrasonography at 66% distal length of calf length and 50% distal thigh length
28 days- change from pre- to post- intervention period
Postural sway during standing balance with eyes open and closed
Time Frame: 28 days- change from pre- to post- intervention period
Measured using a force plate
28 days- change from pre- to post- intervention period
Single leg balance
Time Frame: 28 days- change from pre- to post- intervention period
Measured using the Y-balance test
28 days- change from pre- to post- intervention period
Six minute walk test
Time Frame: 28 days- change from pre- to post- intervention period
The participant will be asked to walk as many times between two cones places 15 meters apart as possible in six minutes.
28 days- change from pre- to post- intervention period
Movement co-ordination during walking and sit to stands
Time Frame: 28 days- change from pre- to post- intervention period
Measured by Qualisys motion capture and force plates
28 days- change from pre- to post- intervention period
Central drive of the plantar flexors
Time Frame: 28 days- change from pre- to post- intervention period
Measured through the interpolated twitch technique
28 days- change from pre- to post- intervention period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Keith Stokes, PhD, University of Bath

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 20, 2016

Primary Completion (Actual)

June 1, 2017

Study Completion (Actual)

July 1, 2017

Study Registration Dates

First Submitted

December 6, 2016

First Submitted That Met QC Criteria

December 9, 2016

First Posted (Estimate)

December 14, 2016

Study Record Updates

Last Update Posted (Actual)

May 23, 2018

Last Update Submitted That Met QC Criteria

May 21, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • UoB-ESS-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared with other researchers

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle Function

Clinical Trials on Exercise Snacking

Subscribe